Kyle Jenne
Evp, Chf Gl Pdt Str Ofcr at Ionis Pharmaceuticals Inc (IONS)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Apr 17SEC | IONSIonis Pharmaceuticals Inc | Sell | 4,90223,713 held (−17%) | $75.17 | $368K | -42.9% |
| Mar 11SEC | IONSIonis Pharmaceuticals Inc | Sell Plan | 21,19127,800 held (−43%) | $75.50 | $1.6M | -43.1% |
| Mar 11SEC | IONSIonis Pharmaceuticals Inc | Sell Plan | 16,08611,714 held (−58%) | $76.30 | $1.2M | -43.7% |
| Jan 20SEC | IONSIonis Pharmaceuticals Inc | Sell | 1,82316,389 held (−10%) | $75.96 | $138K | -43.5% |
- Sell
Evp, Chf Gl Pdt Str Ofcr Kyle Jenne sold $1.6M of IONS at $75.50 — cuts the stake by 43%; pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Chf Gl Pdt Str Ofcr Kyle Jenne sold $1.2M of IONS at $76.30 — cuts the stake by 58%; pre-scheduled 10b5-1 plan sale.